University of Maryland, Baltimore: Diabetes Mellitus trials
The registry lists 17 Diabetes Mellitus studies with University of Maryland, Baltimore as lead sponsor. 3 are open to participants now and 7 have results posted.
Early Phase 1 4Phase 1 1Phase 2 1Phase 4 2No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Continuous Glucose Monitors (CGMs) and Readmission RatesNot yet recruitingNCT07221812Not applicable
- Improving Glycemic Control With Telemedicine and Smart Insulin PensRecruitingNCT06918977Not applicable
- Pharmacogenetics of Response to Sitagliptin (PRS)Not yet recruitingNCT06813014Phase 4
- Risk Factors, Costs, and Impacts of ED BoardingCompletedNCT07532564Results posted
- Improving Glycemic Control in DM2 Patients in the Ambulatory SettingCompletedNCT04800471Not applicableResults posted
- Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.CompletedNCT02904512Not applicableResults posted
- Pharmacogenetics of SGLT2 InhibitorsTerminatedNCT02462421Phase 4Results posted
- Smart Glucose Meter ProjectTerminatedNCT01341587Not applicableResults posted
- Mobile Diabetes ManagementCompletedNCT01107015Not applicableResults posted
- Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4CompletedNCT00574340Early Phase 1Results posted
- Diabetes Prevention and EducationWithdrawnNCT05769127Not applicable
- Nicotinamide Riboside for Diabetic NeuropathyTerminatedNCT03685253Phase 1/2
- Antioxidant Use in Diabetes to Reduce Oxidative StressTerminatedNCT03056014Early Phase 1
- Group and Mobile Care for Gestational DiabetesCompletedNCT03026218Not applicable
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)CompletedNCT01672255Early Phase 1
- Nutrigenomics of Zinc Supplementation in Insulin Secretion and DiabetesCompletedNCT00981448Not applicable
- Metabolic Causes of Thrombosis in Type 2 Diabetes MellitusCompletedNCT00829699Early Phase 1